Rare but serious risks include: Pancreatitis : Severe abdominal pain should prompt immediate medical attention Gallbladder problems : Rapid weight loss can increase gallstone risk Diabetic retinopathy complications : In people with existing eye disease, rapid glucose improvement may temporarily worsen retinopathy, particularly with semaglutide [14] [15] Hypoglycaemia : Low blood sugar is uncommon with GLP-1 agonists alone but can occur if combined with insulin or sulphonylureas [17] [18] GLP-1 agonists are not recognised to directly cause dangerous blood pressure drops (hypotension) in most patients
If a brands price is suppressed by negotiation, the spread available for a biosimilar or generic to undercut them shrinks, making the generic path less profitable
The wave of launches marks a pivotal shift for Indias nascent GLP-1 market, where high prices had until now limited access despite surging global demand for the therapy
Convenient Capsule Format Easy-to-swallow capsules make daily supplementation simple and hassle-free
261, 300 Laitinen, K
Based on results from the PIONEER project, oral semaglutide has been approved for treatment in patients with type 2 diabetes, where a 14 mg dose can reduce hemoglobin A1c (HbA1c) levels by up to 1.4% and lead to a weight loss of up to 4.4 kg
,aspect=ignore)
